Area of research
Radiology, Nuclear Medicine and Imaging · Biomedical Engineering
Research interest
Research interests include Radiomics and Machine Learning in Medical Imaging, Advanced X-ray and CT Imaging, Medical Imaging Techniques and Applications, and MRI in cancer diagnosis.
Structured reporting of neuroendocrine tumors in PET/CT using [18F]SiTATE - impact on interdisciplinary communication
Targeting tumoral heterogeneity in lung cancer: a novel, CT-texture-guided targeted biopsy approach with exome sequencing
Phantom-based radiomics feature test–retest stability analysis on photon-counting detector CT
Tumor classification of gastrointestinal liver metastases using CT-based radiomics and deep learning
Periaortic adipose radiomics texture features associated with increased coronary calcium score—first results on a photon-counting-CT
Evaluation of radiomics feature stability in abdominal monoenergetic photon counting CT reconstructions
Comparison Study of Myocardial Radiomics Feature Properties on Energy-Integrating and Photon-Counting Detector CT
Myocardial Radiomics Texture Features Associated with Increased Coronary Calcium Score—First Results of a Photon-Counting CT
Influence of local aortic calcification on periaortic adipose tissue radiomics texture features—a primary analysis on PCCT
Multiparametric prostate MRI and structured reporting: benefits and challenges in the PI-RADS era
Comparison of Magnetic Resonance Imaging and Contrast-Enhanced Ultrasound as Diagnostic Options for Unclear Cystic Renal Lesions: A Cost-Effectiveness Analysis
The role of structured reporting and structured operation planning in functional endoscopic sinus surgery
Impact of Size and Location of Metastases on Early Tumor Shrinkage and Depth of Response in Patients With Metastatic Colorectal Cancer: Subgroup Findings of the Randomized, Open-Label Phase 3 Trial FIRE-3/AIO KRK-0306
Dynamics in treatment response and disease progression of metastatic colorectal cancer (mCRC) patients with focus on BRAF status and primary tumor location: analysis of untreated RAS-wild-type mCRC patients receiving FOLFOXIRI either with or without panitumumab in the VOLFI trial (AIO KRK0109)
FOLFOXIRI Plus Panitumumab As First-Line Treatment of <i>RAS</i> Wild-Type Metastatic Colorectal Cancer: The Randomized, Open-Label, Phase II VOLFI Study (AIO KRK0109)
Radiomic Analysis Reveals Prognostic Information in T1-Weighted Baseline Magnetic Resonance Imaging in Patients With Glioblastoma
Diagnosis of Calcific Tendonitis of the Rotator Cuff by Using Susceptibility-weighted MR Imaging